Can drowsiness be a side effect of citalopram (Celexa)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, sleepiness (somnolence/drowsiness) is a recognized side effect of citalopram (Celexa).

Somnolence occurs in approximately 18% of patients taking citalopram compared to 10% on placebo, making it one of the most common adverse effects of this medication 1. This represents a clinically meaningful difference that patients and prescribers should anticipate.

Understanding the Side Effect Profile

The drowsiness associated with citalopram is:

  • Common and well-documented: Listed as a frequent adverse event in FDA labeling, occurring in nearly 1 in 5 patients 1
  • Generally mild to moderate: Most cases are transient and manageable 2
  • Part of the broader SSRI class effect: Guidelines note that SSRIs as a class can cause "insomnia or somnolence" 3

Clinical Context and Management

The occurrence of somnolence with citalopram should be weighed against its overall tolerability profile. Citalopram is described as "well tolerated" in clinical guidelines, though "some patients experience nausea and sleep disturbances" 3. The sleep disturbances can manifest as either insomnia (15% of patients) or somnolence (18% of patients) 1.

Important considerations:

  • Dose relationship: While somnolence is common, it showed a positive dose-response relationship in controlled trials 1, meaning higher doses may increase the likelihood or severity of drowsiness

  • Timing of administration: Though not explicitly stated in the evidence for citalopram specifically, the medication can be given morning or evening 3, and timing adjustments may help manage drowsiness

  • Discontinuation rates: Somnolence led to treatment discontinuation in 2% of patients (compared to 1% on placebo) 1, indicating that while common, it's usually tolerable

Special Populations at Higher Risk

Elderly patients and those with neurodegenerative conditions may experience more pronounced sedation 4. In overdose situations, drowsiness becomes more severe and can progress to decreased consciousness or coma 5, 6.

Common Pitfalls to Avoid:

  • Don't dismiss patient reports of excessive sleepiness—this is a legitimate and common side effect
  • Don't assume all patients will experience the same degree of sedation; individual variation is substantial
  • Be cautious when combining citalopram with other sedating medications, as effects can be additive 7

Other Frequent Side Effects to Monitor

Beyond somnolence, patients commonly experience 1:

  • Nausea (21%)
  • Dry mouth
  • Increased sweating
  • Insomnia (paradoxically, in some patients)
  • Sexual dysfunction (particularly ejaculatory delay in males at 6%)

The decision to continue citalopram despite somnolence should balance the therapeutic benefit for depression or anxiety against the impact of drowsiness on daily functioning. If drowsiness is problematic, dose adjustment, timing changes, or switching to an alternative SSRI with a different side effect profile (such as fluoxetine, which is described as "activating" 3) may be warranted.

References

Research

Overview of the safety of citalopram.

Psychopharmacology bulletin, 2003

Guideline

management of rem sleep behavior disorder: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2023

Research

Citalopram Overdose: a Fatal Case.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.